Latest Quarterly Activity Report News

Elsight delivered US$25.8 million in unaudited revenue for the first nine months of 2026, up 91% on the prior corresponding period, but a weaker-than-expected third quarter produced a non-GAAP loss. The company is relying on expanded US defence procurement access, new products and a US$196 million opportunity pipeline to support future growth.

Lion Energy has completed the sale of its Seram Non-Bula interest and is preparing to spud the 12 million barrel Bula Karang-1 prospect in November. The stronger cash position comes with a near-term financing question: its fully drawn A$1.6 million convertible note matures at the end of December.

4DMedical reported a record first quarter, with scan volumes up 61% to 119,672 and unaudited operating revenue rising 66% to $2.3 million. New contracts across the US, Germany and Australia broaden the commercial story, while $242.8 million in cash gives the company room to keep investing.

Metal Bank has shifted its first-production focus to the larger Homestead deposit in Western Australia, targeting production in 2027 as mining approvals and technical studies advance. The company also raised a further $752,400 after quarter end, but the path from resource to mine still depends on drilling, metallurgy, approvals and funding.

Conrad Asia Energy has moved the US$320 million Mako gas project into full-scale fabrication after completing its 75% farm-down to Nations and securing a domestic gas sales route into Batam. The project remains fully funded, with first gas targeted for the fourth quarter of 2027, although Conrad’s cash position remains modest and further carry-loan drawdowns are expected.

Aurelia Metals generated its strongest quarterly Cobar operating cash flow since 2018 as higher gold, copper and zinc production lifted cash to A$160.7 million. The company reaffirmed FY27 guidance while moving closer to a major Peak processing expansion.

Boss Energy has maintained FY27 production and cost guidance after a weather-disrupted quarter, while its new wide-spaced wellfield design points to production at Honeymoon through at least FY34. The next test is whether early operating data can validate the study’s assumptions and support a larger regional uranium hub.

Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.

Deep Yellow has pushed back its targeted fourth-quarter Final Investment Decision for the Tumas uranium project, citing unfavourable equity market conditions. The delay comes as engineering reaches 85%, construction works begin and cash falls to A$144.7 million.

Axiant Resources has completed geophysical work that identified new, untested targets beneath and beside historical drilling at its Shoobridge Gold Project. The newly listed explorer held $6.1 million in cash at quarter-end and is preparing to begin its maiden drilling campaign.

Yari Resources has completed the Arcadia acquisition, lifting its combined reported Queensland coal resources to 504.9Mt and materially increasing its Indicated inventory. The enlarged portfolio brings product flexibility and infrastructure access, but also leaves Yari with technical work, contingent obligations and roughly two quarters of cash funding.

West African Resources delivered record quarterly gold production of 127,950 ounces and generated A$458.2 million in operating cash flow, lifting cash to A$1.195 billion. The strong quarter keeps 2026 production guidance within reach, while Kiaka’s explosives constraint and a pending ownership transaction remain key execution issues.